BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36052162)

  • 21. Recombinant expression of Ixolaris, a Kunitz-type inhibitor from the tick salivary gland, for NMR studies.
    De Paula VS; Silva FHS; Francischetti IMB; Monteiro RQ; Valente AP
    Protein Expr Purif; 2017 Nov; 139():49-56. PubMed ID: 28734839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis.
    Ventura JS; Faria F; Batista IF; Simons SM; Oliveira DG; Morais KL; Chudzinski-Tavassi AM
    Biomed Pharmacother; 2013 Apr; 67(3):192-6. PubMed ID: 23433900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the Salivary Gland Transcriptome of Unfed and Partially Fed
    Esteves E; Maruyama SR; Kawahara R; Fujita A; Martins LA; Righi AA; Costa FB; Palmisano G; Labruna MB; Sá-Nunes A; Ribeiro JMC; Fogaça AC
    Front Cell Infect Microbiol; 2017; 7():476. PubMed ID: 29209593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells.
    Drewes CC; Dias RY; Branco VG; Cavalcante MF; Souza JG; Abdalla DS; Chudzinski-Tavassi AM; Farsky SH
    Toxicon; 2015 Jul; 101():1-10. PubMed ID: 25912945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
    Lockett JM; Mast AE
    Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution and Pharmacokinetics of Amblyomin-X, a Novel Antitumour Protein Drug in Healthy Mice.
    Boufleur P; Sciani JM; Goldfeder M; Faria F; Branco V; Chudzinski-Tavassi AM
    Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):111-120. PubMed ID: 30132264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).
    Dockal M; Hartmann R; Fries M; Thomassen MC; Heinzmann A; Ehrlich H; Rosing J; Osterkamp F; Polakowski T; Reineke U; Griessner A; Brandstetter H; Scheiflinger F
    J Biol Chem; 2014 Jan; 289(3):1732-41. PubMed ID: 24275667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model.
    Lichtenstein F; Iqbal A; de Lima Will SEA; Bosch RV; DeOcesano-Pereira C; Goldfeder MB; Chammas R; Trufen CEM; Morais KLP; de Souza JG; Natalino RJM; de Azevedo IJ; Nishiyama Junior MY; Oliveira U; Alves FIA; Araujo JM; Lobba ARM; Chudzinski-Tavassi AM
    Sci Rep; 2020 Apr; 10(1):6388. PubMed ID: 32286411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
    Peraramelli S; Suylen DP; Rosing J; Hackeng TM
    Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
    Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
    J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution, expansion and expression of the Kunitz/BPTI gene family associated with long-term blood feeding in Ixodes Scapularis.
    Dai SX; Zhang AD; Huang JF
    BMC Evol Biol; 2012 Jan; 12():4. PubMed ID: 22244187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade.
    Nazareth RA; Tomaz LS; Ortiz-Costa S; Atella GC; Ribeiro JM; Francischetti IM; Monteiro RQ
    Thromb Haemost; 2006 Jul; 96(1):7-13. PubMed ID: 16807644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the evolutionary structural variability and target specificity of tick salivary Kunitz peptides using next generation transcriptome data.
    Schwarz A; Cabezas-Cruz A; Kopecký J; Valdés JJ
    BMC Evol Biol; 2014 Jan; 14():4. PubMed ID: 24397261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X.
    Pavon LF; Capper D; Sibov TT; de Toledo SRC; Thomale UW; de Souza JG; Cabral FR; Berra CM; Silva da Costa MD; Mendonça Niçacio J; Dastoli PA; de Oliveira DM; Malheiros SMF; da Cruz EF; Malheiros JM; de Oliveira SM; Silva NS; Petrilli AS; Cappellano AM; Brunialti MC; Salomão R; de Paiva Neto MA; Chudzinski-Tavassi AM; Cavalheiro S
    Sci Rep; 2019 Jul; 9(1):9973. PubMed ID: 31292491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small protease inhibitors in tick saliva and salivary glands and their role in tick-host-pathogen interactions.
    Martins LA; Kotál J; Bensaoud C; Chmelař J; Kotsyfakis M
    Biochim Biophys Acta Proteins Proteom; 2020 Feb; 1868(2):140336. PubMed ID: 31816416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of anticoagulant and anticomplement activity of the tick salivary protein Salp14 and its homologs.
    Denisov SS; Ippel JH; Castoldi E; Mans BJ; Hackeng TM; Dijkgraaf I
    J Biol Chem; 2021 Jul; 297(1):100865. PubMed ID: 34118237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tick Salivary Kunitz-Type Inhibitors: Targeting Host Hemostasis and Immunity to Mediate Successful Blood Feeding.
    Jmel MA; Voet H; Araújo RN; Tirloni L; Sá-Nunes A; Kotsyfakis M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.
    Monteiro RQ; Rezaie AR; Bae JS; Calvo E; Andersen JF; Francischetti IM
    Protein Sci; 2008 Jan; 17(1):146-53. PubMed ID: 18042685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant activity in salivary glands of the insect vector Culicoides variipennis sonorensis by an inhibitor of factor Xa.
    Pérez de León AA; Valenzuela JG; Tabachnick WJ
    Exp Parasitol; 1998 Feb; 88(2):121-30. PubMed ID: 9538866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.